Author： Fiedler Beate Wollert Kai C
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.5, 2005-10, pp. : 963-973
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeting microRNAs in Pathological Hypertrophy and Cardiac Failure
Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 6, 2015-05 ,pp. :
Access to resources
Recommend
By Lu Cui-cui Xu Ying-qi Wu Ji-chao Hang Peng-zhou Wang Yan Wang Chen Wu Jian-wei Qi Jian-cui Zhang Yong Du Zhi-min
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 386, Iss. 8, 2013-08 ,pp. :
The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design, Vol. 23, Iss. 11, 2017-05 ,pp. :
Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. :
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. :